Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Daiichi Sankyo gains Brazilian rights, other options on Mitsubishi Tanabe's edaravone for ALS

Executive Summary

Mitsubishi Tanabe Pharma Corp. granted Daiichi Sankyo Co. Ltd. commercialization rights in Brazil for an intravenous infusion formulation of edaravone for amyotrophic lateral sclerosis (ALS).
Deal Industry
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing

Related Companies